Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 04, 2022

SELL
$13.01 - $27.22 $60,444 - $126,464
-4,646 Reduced 85.31%
800 $11,000
Q1 2022

Apr 14, 2022

SELL
$20.94 - $27.5 $616,871 - $810,122
-29,459 Reduced 84.4%
5,446 $131,000
Q4 2021

Jan 18, 2022

BUY
$16.79 - $27.09 $460,129 - $742,401
27,405 Added 365.4%
34,905 $814,000
Q3 2021

Oct 26, 2021

BUY
$15.78 - $24.77 $116,772 - $183,298
7,400 Added 7400.0%
7,500 $124,000
Q1 2021

Apr 26, 2021

SELL
$25.02 - $54.99 $100,080 - $219,960
-4,000 Reduced 97.56%
100 $2,000
Q4 2019

Feb 06, 2020

BUY
$36.21 - $51.4 $29,945 - $42,507
827 Added 25.27%
4,100 $175,000
Q3 2019

Oct 28, 2019

SELL
$22.22 - $44.01 $80,103 - $158,656
-3,605 Reduced 52.41%
3,273 $117,000
Q1 2019

May 10, 2019

BUY
$16.17 - $27.38 $64,857 - $109,821
4,011 Added 139.9%
6,878 $184,000
Q4 2018

Feb 05, 2019

BUY
$14.32 - $22.92 $4,668 - $7,471
326 Added 12.83%
2,867 $46,000
Q2 2018

Aug 10, 2018

SELL
$15.07 - $22.34 $455,038 - $674,556
-30,195 Reduced 92.24%
2,541 $38,000
Q1 2018

May 11, 2018

BUY
$22.47 - $32.33 $412,661 - $593,740
18,365 Added 127.79%
32,736 $735,000
Q4 2017

Jan 17, 2018

SELL
$26.84 - $39.14 $74,427 - $108,535
-2,773 Reduced 16.17%
14,371 $432,000
Q3 2017

Oct 17, 2017

BUY
$29.49 - $38.37 $505,576 - $657,815
17,144
17,144 $645,000

Others Institutions Holding ACAD

About ACADIA PHARMACEUTICALS INC


  • Ticker ACAD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 161,843,008
  • Market Cap $2.65B
  • Description
  • ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...
More about ACAD
Track This Portfolio

Track Cutler Group LP Portfolio

Follow Cutler Group LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutler Group LP with notifications on news.